Correlation Between Cns Pharmaceuticals and Altamira Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cns Pharmaceuticals and Altamira Therapeutics, you can compare the effects of market volatilities on Cns Pharmaceuticals and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Altamira Therapeutics.

Diversification Opportunities for Cns Pharmaceuticals and Altamira Therapeutics

0.69

Correlation Coefficient

Cns Pharmaceuticals  Altamira Therapeutics

Poor diversification

The 3 months correlation between Cns and Altamira is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Altamira Therapeutics go up and down completely randomly.

Pair Corralation between Cns Pharmaceuticals and Altamira Therapeutics

Given the investment horizon of 90 days Cns Pharmaceuticals is expected to generate 1.4 times more return on investment than Altamira Therapeutics. However, Cns Pharmaceuticals is 1.4 times more volatile than Altamira Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Altamira Therapeutics is currently generating about -0.21 per unit of risk. If you would invest  15.00  in Cns Pharmaceuticals on September 2, 2024 and sell it today you would lose (4.00) from holding Cns Pharmaceuticals or give up 26.67% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Cns Pharmaceuticals  vs.  Altamira Therapeutics

Cns Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Altamira Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Altamira Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Cns Pharmaceuticals and Altamira Therapeutics

The main advantage of trading using opposite Cns Pharmaceuticals and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.

The idea behind Cns Pharmaceuticals and Altamira Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.